<p>Positive top-line Phase 1 data for lead clinical program DNTH103 confirm potent classical pathway inhibition, extended half-life, and a potentially differentiated safety profile Results suppo
<p>Shares of defense companies leaped amid the fighting in Israel and Gaza. Major U.S.-listed companies rose in early trading: Lockheed Martin was up more than 7%, while Northrop Grumman climbed
Leave a Comment